Evidence map›Paper›PMID 40585647›Full record

ArticleCureus2025

Orbital Myeloid Sarcoma as the Initial Presentation of Acute Myeloid Leukemia With Maturation in a Pediatric Patient: A Case Report.

Moath Altarawneh, Alaa Alqasem, Mousa Qatawneh, Ayman Alhwayan, Firas Alsmadi, Mohammad Alsaaida, Amani Alrousan, Hind Alqatamin, Haneen Alrawashdeh, Maher Khader

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Moath AltarawnehPaediatric Haematology-Oncology, Royal Medical Services-Queen Rania Children's Hospital, Amman, JOR.
Alaa AlqasemPaediatric Haematology-Oncology, Royal Medical Services-Queen Rania Children's Hospital, Amman, JOR.
Mousa QatawnehPaediatric Haematology-Oncology, Royal Medical Services-Queen Rania Children's Hospital, Amman, JOR.
Ayman AlhwayanPaediatric Haematology-Oncology, Royal Medical Services-Queen Rania Children's Hospital, Amman, JOR.
Firas AlsmadiPaediatric Radiology, Royal Medical Services-Queen Rania Children's Hospital, Amman, JOR.
Mohammad AlsaaidaPaediatric Ophthalmology, Royal Medical Services-Queen Rania Children's Hospital, Amman, JOR.
Amani AlrousanPathology and Laboratory Medicine, Royal Medical Services- Princess Iman Center for Research and Laboratory, Amman, JOR.
Hind AlqataminPathology and Laboratory Medicine, Royal Medical Services-Princess Iman Center for Research and Laboratory, Amman, JOR.
Haneen AlrawashdehPaediatric Haematology-Oncology, Royal Medical Services-Queen Rania Children's Hospital, Amman, JOR.
Maher KhaderPaediatric Haematology-Oncology, Royal Medical Services-Queen Rania Children's Hospital, Amman, JOR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myeloid leukemia (AML) is primarily a disease of adulthood but can also occur in children. Myeloid sarcoma (MS) is an uncommon extramedullary manifestation of AML, and orbital involvement is considered particularly rare, especially in pediatric cases. We report a case of a four-year-old girl from Gaza who developed progressively worsening bilateral orbital swelling and ptosis over four months. Initial assessments, including an eyelid biopsy performed in Gaza, suggested a possible diagnosis of lymphangioma or rhabdomyosarcoma. However, limited access to advanced diagnostic resources and delays in cross-border referral significantly impacted definitive diagnosis. When she was finally referred to Jordan, advanced imaging revealed extensive bilateral retro-orbital masses, severe proptosis, and orbital wall erosion. Histopathological analysis confirmed that MS and bone marrow studies identified AML with maturation (French-American-British classification subtype M2 (FAB-M2)) and the translocation of t (8;21). Despite undergoing three cycles of chemotherapy, she tragically passed away just four months after diagnosis due to complications including encephalopathy and severe infection. This case highlights the aggressive nature of orbital MS in pediatric AML and the critical role of timely access to advanced medical care. It also highlights the devastating impact of healthcare inequities in conflict zones, where diagnostic and treatment delays can significantly worsen outcomes.

Indexed as

acute myeloid leukemiacross-border healthcareorbital myeloid sarcomapediatric oncologyrare hematological malignancies

Identifiers

PMID40585647
PMCPMC12205632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.